BioNTech Past Earnings Performance
Past criteria checks 5/6
BioNTech has been growing earnings at an average annual rate of 86.7%, while the Biotechs industry saw earnings growing at 16.9% annually. Revenues have been growing at an average rate of 85.7% per year. BioNTech's return on equity is 56.2%, and it has net margins of 55.6%.
Key information
86.7%
Earnings growth rate
86.6%
EPS growth rate
| Biotechs Industry Growth | 14.2% |
| Revenue growth rate | 85.7% |
| Return on equity | 56.2% |
| Net Margin | 55.6% |
| Next Earnings Update | 27 Mar 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How BioNTech makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 22 | 18,565 | 10,322 | 565 | 1,299 |
| 30 Jun 22 | 21,191 | 11,748 | 490 | 1,217 |
| 31 Mar 22 | 23,303 | 12,863 | 403 | 1,019 |
| 31 Dec 21 | 18,977 | 10,293 | 346 | 949 |
| 30 Sep 21 | 13,790 | 7,493 | 229 | 935 |
| 30 Jun 21 | 7,770 | 4,072 | 178 | 902 |
| 31 Mar 21 | 2,503 | 1,197 | 139 | 796 |
| 31 Dec 20 | 482 | 15 | 107 | 645 |
| 30 Sep 20 | 165 | -410 | 79 | 453 |
| 30 Jun 20 | 126 | -230 | 63 | 275 |
| 31 Mar 20 | 110 | -192 | 57 | 232 |
| 31 Dec 19 | 109 | -179 | 49 | 227 |
| 30 Sep 19 | 144 | -122 | 53 | 208 |
| 30 Jun 19 | 136 | -116 | 48 | 191 |
| 31 Mar 19 | 132 | -77 | 38 | 168 |
| 31 Dec 18 | 128 | -48 | 32 | 141 |
| 31 Dec 17 | 62 | -86 | 34 | 82 |
Quality Earnings: 22UA has high quality earnings.
Growing Profit Margin: 22UA's current net profit margins (55.6%) are higher than last year (54.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 22UA's earnings have grown significantly by 86.7% per year over the past 5 years.
Accelerating Growth: 22UA's earnings growth over the past year (37.8%) is below its 5-year average (86.7% per year).
Earnings vs Industry: 22UA earnings growth over the past year (37.8%) exceeded the Biotechs industry -26.8%.
Return on Equity
High ROE: 22UA's Return on Equity (56.2%) is considered outstanding.